Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Capital Ventures (often referred to as AMCAP Ventures) was the venture capital and private equity arm of American Capital, Ltd., a prominent global asset manager. The firm specialized in providing growth capital and buyout financing to middle-market companies across various sectors, with a significant focus on life sciences, healthcare services, and technology. Within the healthcare space, the firm's portfolio included notable investments in biotechnology companies such as MacroGenics, Cempra, and Symphogen. In January 2017, American Capital was acquired by Ares Management, leading to the integration of its assets and investment teams into the Ares platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMCAP Ventures.